Shopping Cart
Remove All
Your shopping cart is currently empty
The Survival of Motor Neurons (SMN) protein participates in RNA splicing. Decreases in SMN, typically a consequence of defects in the smn1 gene, result in the death of motor neurons and lead to the neurodegenerative disease, spinal muscular atrophy (SMA). Cuspin-1 is a small molecule upregulator of SMN that has been shown in vitro to increase levels of SMN in SMA patient fibroblasts by 50% at 18 μM. Its mechanism of action is thought to involve increased phosphorylation of ERK to initiate Ras-Raf-MEK signaling, which results in an increased rate of SMN translation.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $143 | 35 days | 35 days | |
| 10 mg | $238 | 35 days | 35 days | |
| 25 mg | $520 | 35 days | 35 days | |
| 50 mg | $960 | 35 days | 35 days |
| Description | The Survival of Motor Neurons (SMN) protein participates in RNA splicing. Decreases in SMN, typically a consequence of defects in the smn1 gene, result in the death of motor neurons and lead to the neurodegenerative disease, spinal muscular atrophy (SMA). Cuspin-1 is a small molecule upregulator of SMN that has been shown in vitro to increase levels of SMN in SMA patient fibroblasts by 50% at 18 μM. Its mechanism of action is thought to involve increased phosphorylation of ERK to initiate Ras-Raf-MEK signaling, which results in an increased rate of SMN translation. |
| Molecular Weight | 276.13 |
| Formula | C13H10BrNO |
| Cas No. | 337932-29-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: 16 mg/mL (57.94 mM), Sonication is recommended. Ethanol: 1 mg/mL (3.62 mM), Sonication is recommended. DMF: 25 mg/mL (90.54 mM), Sonication is recommended. DMF:PBS(pH 7.2)(1:1): 0.5 mg/mL (1.81 mM), Sonication is recommended. |
Solution Preparation Table | |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.